Dvago Logo
    location icon

    Dvago Logo

    Delivers in

      location icon

      targocid im/iv injection 200mg (1 box = 1 injection) Product Image

      Targocid Im/Iv Injection 200Mg (1 Box = 1 Injection)

      Rs. 2,138.01

      Rs. 2,250.54



      Targocid Im/Iv Specification

      Requires Prescription (YES/NO)




      Used For

      Bacterial Infection

      How it works

      Teicoplanin inhibits the growth of susceptible organisms by interfering with cell-wall biosynthesis at a site different from that affected by beta-lactams. Peptidoglycan synthesis is blocked by specific binding to D-alanyl-D-alanine residues.

      Targocid Im/Iv Usage And Safety



      Side Effects

      Common (may affect up to 1 in 10 people) : • Rash, erythema, pruritus • Pain • FeverUncommon (may affect up to 1 in 100 people) : • decrease in platelet count. • raised blood levels of liver enzymes • raised in blood levels of creatinine (tomonitor your kidney) • hearing loss, ringing in the ears or a feeling that you, or things around you are moving • feeling or being sick (vomiting), diarrhoea • feeling dizzy or headacheRare (may affect up to 1 in 1,000 people) : • infection (abscess). Not known (frequency cannot be estimated from the available data) : • problems where the injection was given - such as reddening of the skin, pain or swelling

      Drug Interactions

      Aminoglycosides, colistin, amphotericin B, ciclosporin, cisplatin, furosemide, and ethacrynic acid .


      It is used in adults and children (including newborn babies) to treat bacterial infections of:- The skin and underneath the skin - sometimes called ‘soft tissue’- The bones and joints- The lung- The urinary tract- The heart - sometimes called ‘endocarditis’- The abdominal wall - peritonitis- The blood, when caused by any of the conditions listed above.

      When not to Use

      Do not use Teicoplanin if you are allergic to teicoplanin or any of the other ingredients of this medicine.

      Targocid Im/Iv Precautions


      Serious, life-threatening hypersensitivity reactions, sometimes fatal, have been reported with teicoplanin (e.g. anaphylactic shock). If an allergic reaction to teicoplanin occurs, treatment should be discontinued immediately and appropriate emergency measures should be initiated.

      Targocid Im/Iv Warnings

      Warning 1

      In rare cases (even at the first dose), red man syndrome (a complex of symptoms including pruritus, urticaria, erythema, angioneurotic oedema, tachycardia, hypotension, dyspnoea) has been observed. Stopping or slowing the infusion may result in cessation of these reactions. Infusion related reactions can be limited if the daily dose is not given via bolus injection but infused over a 30-minute period.

      Warning 2

      Life-threatening or even fatal cutaneous reactions Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been reported with the use of teicoplanin. If symptoms or signs of SJS or TEN (e.g. progressive skin rash often with blisters or mucosal lesions) are present teicoplanin treatment should be discontinued immediately.

      Warning 3

      The rational use of teicoplanin should take into account the bacterial spectrum of activity, the safety profile and the suitability of standard antibacterial therapy to treat the individual patient. On this basis it is expected that in most instances teicoplanin will be used to treat severe infections in patients for whom standard antibacterial activity is considered to be unsuitable.

      Targocid Im/Iv Additional Information

      Pregnancy category

      Always consult your physician before using any medicine.

      Storage (YES/NO)

      Store this medicine at room temperature, away from direct light and heat.

      Related Products